Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma

George Bozas; Aristotle Bamias; Vassiliki Koutsoukou; Eleni Efstathiou; Dimitra Gika; Christos Papadimitriou; Meletios A Dimopoulos

doi:10.1016/j.ygyno.2006.09.006

Related publications

Article2003

Phase II study of docetaxel–vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer

Gerasimos Aravantinos, Dimitrios Bafaloukos, George Fountzilas, Christos Christodoulou, Christos Papadimitriou, N Pavlidis, Haralabos P. Kalofonos, Helen Gogas, P. Kosmidis, Meletios A Dimopoulos

Article2000

Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer

Gerasimos Aravantinos, Meletios A Dimopoulos, P Kosmidis, Dimitrios Bafaloukos, Christos Papadimitriou, Christos Kiamouris, N. Pavlidis, K. Sikiotis, Pavlos Papakostas, D. Skarlos

Article1999

Docetaxel-vinorelbine combination for platinum resistant paclitaxel pretreated ovarian cancer. A hellenic co-operative oncology group phase II study

Gerasimos Aravantinos, Dimitrios Bafaloukos, Meletios A Dimopoulos, C. Nikolaides, Pavlos Papakostas, Christos Kiamouris, K. Sikiotis, T. Rapsomaniki, George Fountzilas, D. Skarlos

Article2012

Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents

Aristotle Bamias, Christine Bamia, Flora Zagouri, Efthimios Kostouros, Konstantina Kakoyianni, Alexandros Rodolakis, George Vlahos, Dimitrios Haidopoulos, Nikolaos Thomakos, Aris Antsaklis, Meletios A Dimopoulos

Article2000

Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in Stage III and IV ovarian carcinoma

C.A. Papadimitriou, Lia A. Moulopoulos, Georgios Vlahos, Zannis Voulgaris, Evangelos Kiosses, Nikolaos Georgoulias, Dimitra Gika, Emmanuel Diakomanolis, Stylianos Michalas, Meletios A Dimopoulos